Marion van der Kolk1,2, Mark van den Boogaard3, Femke Becking-Verhaar4, Hettie Custers5, Hans van der Hoeven3, Peter Pickkers3, Kees van Laarhoven4. 1. Department of Surgery, Radboud University Medical Center, P.O. Box 9101, 6500HB, Nijmegen, The Netherlands. Marion.vanderKolk@radboudumc.nl. 2. Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Marion.vanderKolk@radboudumc.nl. 3. Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Department of Surgery, Radboud University Medical Center, P.O. Box 9101, 6500HB, Nijmegen, The Netherlands. 5. Department of Anesthesiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Abstract
INTRODUCTION: Medical and nursing protocols in perioperative care for pancreaticoduodenectomy are mainly mono-disciplinary, limiting their integration and transparency in a continuous health care system. The aims of this study were to evaluate adherence to a multidisciplinary clinical pathway for all pancreaticoduodenectomy patients during their entire hospital stay and to determine if the use of this clinical pathway is associated with beneficial effects on clinical end points. MATERIALS AND METHODS: A prospective cohort study was conducted in 95 pancreaticoduodenectomy patients treated according to a clinical pathway, including a variance report, compared to a historical control group (n = 52) with a traditional treatment regime. RESULTS: Process evaluation of the clinical pathway group revealed that protocol adherence throughout all units was above 80%. Major complications according to Clavien-Dindo classification grade ≥3 decreased from 27 to 13%; p = 0.02. Hospital length of stay was significantly shorter in the clinical pathway group, median 10 days [IQR 8-15], compared with the control group, median 13 days [IQR 10-18]; p = 0.02. CONCLUSION: The use of a clinical pathway in pancreaticoduodenectomy patients was associated with high protocol adherence, improved outcome and shorter hospital length of stay. Variance report analysis and protocol adherence with a Prepare-Act-Reflect Cycle are essential in surveillance of outcome.
INTRODUCTION: Medical and nursing protocols in perioperative care for pancreaticoduodenectomy are mainly mono-disciplinary, limiting their integration and transparency in a continuous health care system. The aims of this study were to evaluate adherence to a multidisciplinary clinical pathway for all pancreaticoduodenectomy patients during their entire hospital stay and to determine if the use of this clinical pathway is associated with beneficial effects on clinical end points. MATERIALS AND METHODS: A prospective cohort study was conducted in 95 pancreaticoduodenectomy patients treated according to a clinical pathway, including a variance report, compared to a historical control group (n = 52) with a traditional treatment regime. RESULTS: Process evaluation of the clinical pathway group revealed that protocol adherence throughout all units was above 80%. Major complications according to Clavien-Dindo classification grade ≥3 decreased from 27 to 13%; p = 0.02. Hospital length of stay was significantly shorter in the clinical pathway group, median 10 days [IQR 8-15], compared with the control group, median 13 days [IQR 10-18]; p = 0.02. CONCLUSION: The use of a clinical pathway in pancreaticoduodenectomy patients was associated with high protocol adherence, improved outcome and shorter hospital length of stay. Variance report analysis and protocol adherence with a Prepare-Act-Reflect Cycle are essential in surveillance of outcome.
Authors: Sydney M Dy; Pushkal Garg; Dorothy Nyberg; Patricia B Dawson; Peter J Pronovost; Laura Morlock; Haya Rubin; Albert W Wu Journal: Health Serv Res Date: 2005-04 Impact factor: 3.402
Authors: Charles C Hsu; Christopher L Wolfgang; Daniel A Laheru; Timothy M Pawlik; Michael J Swartz; Jordan M Winter; Raymond Robinson; Barish H Edil; Amol K Narang; Michael A Choti; Ralph H Hruban; John L Cameron; Richard D Schulick; Joseph M Herman Journal: J Gastrointest Surg Date: 2012-02-07 Impact factor: 3.452
Authors: Arman Kahokehr; Tarik Sammour; Kamran Zargar-Shoshtari; Lisa Thompson; Andrew G Hill Journal: Int J Surg Date: 2008-12-03 Impact factor: 6.071
Authors: Kristoffer Lassen; Marielle M E Coolsen; Karem Slim; Francesco Carli; José E de Aguilar-Nascimento; Markus Schäfer; Rowan W Parks; Kenneth C H Fearon; Dileep N Lobo; Nicolas Demartines; Marco Braga; Olle Ljungqvist; Cornelis H C Dejong Journal: Clin Nutr Date: 2012-09-26 Impact factor: 7.324
Authors: Marielle M E Coolsen; Ronald M van Dam; Arwind Chigharoe; Steven W M Olde Damink; Cornelis H C Dejong Journal: Dig Surg Date: 2014-07-30 Impact factor: 2.588
Authors: Sebastiaan W Polle; Jan Wind; Jan W Fuhring; Jan Hofland; Dirk J Gouma; Willem A Bemelman Journal: Dig Surg Date: 2007-09-13 Impact factor: 2.588
Authors: Mohammed Abu Hilal; Francesco Di Fabio; Abdallah Badran; Hani Alsaati; Hannah Clarke; Imogen Fecher; Thomas H Armstrong; Colin D Johnson; Neil W Pearce Journal: Pancreatology Date: 2012-12-02 Impact factor: 3.996
Authors: Patrick Téoule; Laura Römling; Matthias Schwarzbach; Emrullah Birgin; Felix Rückert; Torsten J Wilhelm; Marco Niedergethmann; Stefan Post; Nuh N Rahbari; Christoph Reißfelder; Ulrich Ronellenfitsch Journal: Ther Clin Risk Manag Date: 2019-10-01 Impact factor: 2.423
Authors: Yang Cao; Hui-Yun Gu; Zhen-Dong Huang; Ya-Peng Wu; Qiong Zhang; Jie Luo; Chao Zhang; Yan Fu Journal: Front Oncol Date: 2019-07-30 Impact factor: 6.244